<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01916096</url>
  </required_header>
  <id_info>
    <org_study_id>FT-837-068-BV</org_study_id>
    <nct_id>NCT01916096</nct_id>
  </id_info>
  <brief_title>Lancet Blood Volume Comparison Study</brief_title>
  <official_title>Lancet Blood Volume Comparison Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Facet Technologies</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Facet Technologies</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the study examines the success rate of various OneTouch Delica
      lancet sizes across depth settings of the OneTouch Delica lancing device. The sample size is
      based on 30 subjects per lancet size for a given depth setting. Each subject is lanced 4
      times with two lancet sizes at a single depth setting. There will be 120 paired lancing
      events for each lancet size within the group.

      Null hypothesis (H0): there is a 90% success rate of attaining a minimum blood volume of
      1.0μL for the 28g lancet across all depth settings.

      Alternate hypothesis (H1): the success rate of attaining a minimum blood volume of 1.0μL for
      the 28g lancet across all depth settings is less than 90%.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Volume Measurements</measure>
    <time_frame>24 hours</time_frame>
    <description>Lancing events were performed on subjects fingers. After each lancing event blood volume was measure with a scale.</description>
  </primary_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Actual">180</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Delica 28g Depth 3 vs Delica 30g Depth 3</arm_group_label>
    <description>30 subjects with diabetes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delica 28g Depth 5 vs Delica 30g Depth 5</arm_group_label>
    <description>30 subjects with diabetes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delica 28g Depth 7 vs Delica 30g Depth 7</arm_group_label>
    <description>30 subjects with diabetes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delica 28g Depth 3 vs Delica 33g Depth 3</arm_group_label>
    <description>30 subjects with diabetes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delica 28g Depth 5 vs Delica 33g Depth 5</arm_group_label>
    <description>30 subjects with diabetes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delica 28g Depth 7 vs Delica 33g Depth 7</arm_group_label>
    <description>30 subjects with diabetes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Delica Device</intervention_name>
    <arm_group_label>Delica 28g Depth 3 vs Delica 30g Depth 3</arm_group_label>
    <arm_group_label>Delica 28g Depth 5 vs Delica 30g Depth 5</arm_group_label>
    <arm_group_label>Delica 28g Depth 7 vs Delica 30g Depth 7</arm_group_label>
    <arm_group_label>Delica 28g Depth 3 vs Delica 33g Depth 3</arm_group_label>
    <arm_group_label>Delica 28g Depth 5 vs Delica 33g Depth 5</arm_group_label>
    <arm_group_label>Delica 28g Depth 7 vs Delica 33g Depth 7</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        People with diabetes from the surrounding communitu
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must have been diagnosed with type 1 or type 2 diabetes for at least 1 year

          -  Must be doing Blood Glucose Monitoring, at least twice daily for at least 6 months

          -  Subjects must be between 18 and 85 years of age.

          -  Subjects must be able to perform all tasks required in this protocol.

          -  Subjects must be willing to complete all study procedures.

          -  Subjects must be able to speak, read and understand English and understand the
             Informed Consent document.

        Exclusion Criteria:

          -  Subjects with neuropathy or any other nerve damage in the hand or fingers

          -  Subjects who are taking prescription anti-coagulants or more than one full aspirin per
             day during the past week or have clotting problems that may prolong bleeding (persons
             taking Plavix or a daily low dose aspirin will not be excluded but this will be
             recorded).

          -  Subjects taking prescription medications for neuropathy.

          -  Subjects with hemophilia or any other bleeding disorder.

          -  Subjects with infection with a blood borne pathogen (e.g., HIV, hepatitis).

          -  Subjects having a condition such as a cognitive disorder, which in the opinion of the
             Investigator would put the person at risk or seriously compromise the integrity of the
             study (PI will sign case report form if subject is excluded).

          -  Subjects working for Facet, LifeScan Inc., or a competitive company.

          -  Subjects with missing digits.

          -  Subjects who are pregnant or nursing.

          -  Subjects on chemotherapy.

          -  Subjects with poor circulation to the hands as judged by a refill time of more than 5
             seconds
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barry Ginsberg, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Facet Technologies</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Facet Technologies</name>
      <address>
        <city>Kennesaw</city>
        <state>Georgia</state>
        <zip>30144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2013</study_first_submitted>
  <study_first_submitted_qc>August 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2013</study_first_posted>
  <last_update_submitted>August 1, 2013</last_update_submitted>
  <last_update_submitted_qc>August 1, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

